MIRA Pharma Stock Skyrockets 100% Overnight as New Pain Drug Outshines Morphine
MIRA Pharmaceuticals’ stock price skyrocketed overnight on the back of surprising good news. The relatively obscure biotech – which trades on the Nasdaq Capital Market under ticker MIRA – closed Wednesday, Oct. 15 at $1.32 per sharebenzinga.com. That modest close gave little hint of what was to come. After the market shut, MIRA stunned investors with a press release detailing remarkable lab results for its lead drug candidate. The reaction was immediate: shares surged 68.94% in after-hours trading, reaching $2.23benzinga.com. And the rally didn’t stop there. By Thursday morning in pre-market dealings, MIRA’s stock was trading as high as $2.74 – more than double its prior day’s closemarketbeat.com.
